How Life Sciences Can Treat AI Regulatory Compliance
Artificial intelligence, particularly machine learning, encompasses a multifaceted set of technologies with many applications in the life sciences sector, such as cure research, diagnosis, and treatment, mitigation and prevention. Despite the vast potential of AI, the AI regulatory field is in full bloom in some places and merely bare branches elsewhere – depending on public […]
Read More
AI in Life Sciences: Faster and Surer Diagnosis of Disease
While COVID-19 is extracting a terrible price on human life and causing significant economic hardship, it is helping to catalyze a transformation in care delivery. As noted in my prior post, AI is improving and accelerating the discovery of new therapies. Beyond this, AI and machine learning (ML) are also transforming clinical diagnosis, by improving […]
Read More
AI & Data: Our Best Hope for Infectious Disease Prevention, Treatment, Mitigation & Cures
Great challenges require great tools. And in a world where a virus such as SARS-CoV-2 has had a huge global impact in just a matter of months, its complexity and speed require new methods for finding solutions. Advanced forms of artificial intelligence (AI) are already playing a critical role in our pandemic-fighting efforts, and they’re […]
Read More
The Fate of the Next Pandemic Lies in What We Eat
If “wet markets” in Wuhan, China, played an early role in the spread of COVID-19, as is widely believed, the coronavirus pandemic has plenty of company: SARS, MERS, Ebola and other diseases also migrated from animals to humans. It’s impossible to overstate the role of the world’s food supply in the suppression or transmission of […]
Read More
AI in Life Sciences: Faster Cures for Viral Disease
COVID-19 is upending life as we know it. The potential effect of this viral disease on mortality and public health, as well as the lasting socioeconomic impact of the crisis, is unfathomable. To mitigate the wide-scale impact of this growing pandemic, our hopes are trained on a vaccine, prophylactic or curative, and the life sciences […]
Read More
Value-Based Care in Life Sciences: What’s It Worth to You?
Just one of the many changes rippling through the life sciences industry is the gradual but inexorable shift of value-based care (VBC) becoming a leading means of healthcare insurance reimbursement. According to our recently sponsored research, as many as 150 biopharmaceutical drugs are covered by value-based contracts, with a projected growth rate of 15% to […]
Read More
Disaggregation of Healthcare: The Great Unbundling Proceeds
In discussions with our clients, it’s become apparent that one of the greatest changes we’re witnessing in healthcare is the disaggregation (or unbundling) of care. Historically, access to and delivery of healthcare took place primarily in doctors’ offices, hospitals and clinics. However, changes in consumer sentiment and advances in technology are creating a far more […]
Read More
From ‘-Omics’ to Digital Twins, Life Sciences Is In for Vast Changes Ahead
Digital tools and platforms are remaking every aspect of the life sciences (LS) value chain, from co-prescribed apps to implanted sensors to data queries for drug discovery, and digital is overturning how companies conduct clinical trials and manage production/distribution. The changes extend to how individual patients assimilate and internalize health and healthcare technology directly, through […]
Read More